Below are the most recent publications written about "Histoplasma" by people in Profiles.
-
C?ceres DH, Samayoa BE, Medina NG, Tob?n AM, Guzm?n BJ, Mercado D, Restrepo A, Chiller T, Arathoon EE, G?mez BL. Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries. J Clin Microbiol. 2018 06; 56(6).
-
Deepe GS, Buesing WR, Ostroff GR, Abraham A, Specht CA, Huang H, Levitz SM. Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice. Vaccine. 2018 05 31; 36(23):3359-3367.
-
Caceres DH, Scheel CM, Tob?n AM, Ahlquist Cleveland A, Restrepo A, Brandt ME, Chiller T, G?mez BL. Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy. Clin Vaccine Immunol. 2014 Sep; 21(9):1364-8.
-
Arango-Bustamante K, Restrepo A, Cano LE, de Bedout C, Tob?n AM, Gonz?lez A. Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. Am J Trop Med Hyg. 2013 Nov; 89(5):937-42.
-
Schuster JE, Wushensky CA, Di Pentima MC. Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations. Pediatr Infect Dis J. 2013 Jul; 32(7):794-6.
-
Mu?oz C, G?mez BL, Tob?n A, Arango K, Restrepo A, Correa MM, Muskus C, Cano LE, Gonz?lez A. Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America. Clin Vaccine Immunol. 2010 Jan; 17(1):62-7.
-
David C, Martin DB, Deng A, Cooper JZ. Disseminated Trichosporon inkin and Histoplasma capsulatum in a patient with newly diagnosed AIDS. J Am Acad Dermatol. 2008 Aug; 59(2 Suppl 1):S13-5.
-
Restrepo A, Tob?n A, Clark B, Graham DR, Corcoran G, Bradsher RW, Goldman M, Pankey G, Moore T, Negroni R, Graybill JR. Salvage treatment of histoplasmosis with posaconazole. J Infect. 2007 Apr; 54(4):319-27.
-
Goldman M, Zackin R, Fichtenbaum CJ, Skiest DJ, Koletar SL, Hafner R, Wheat LJ, Nyangweso PM, Yiannoutsos CT, Schnizlein-Bick CT, Owens S, Aberg JA. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004 May 15; 38(10):1485-9.
-
Jim?nez RA, Ur?n ME, de Bedout C, Arango M, Tob?n AM, Cano LE, Restrepo A. [Outbreak of acute histoplasmosis in a family group: identification of the infection source]. Biomedica. 2002 Jun; 22(2):155-9.